drugset / Trial / NCT00332345

Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

NCT00332345 ↗

Phase 2 Completed 73 enrolled Allergan
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension

Timeline

Start
1999-07
Primary completion
1999-08
Completion
1999-08

Drugs

EvaluationDrugModalityDoseRoute
Subject brimonidine/timolol Unknown — —

Indications